PROS1 and COVID-19: A bio-layer interferometry (BLI)-based assay using a panel of monoclonal Abs (mAbs) previously isolated from COVID-19 patients was used to confirm the presence of intact S epitopes and, in mosaic NPs, the presence of multiple different S proteins (Figure 1D).